Australia markets closed

Benitec Biopharma Inc. (BNTC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
8.95+0.01 (+0.11%)
At close: 04:00PM EDT
8.77 -0.18 (-2.01%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 23.20M
Enterprise value 3.25M
Trailing P/E 51.55
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)102.69
Price/book (mrq)1.50
Enterprise value/revenue 53.30
Enterprise value/EBITDA -0.15

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 3137.14%
S&P500 52-week change 322.38%
52-week high 310.29
52-week low 31.86
50-day moving average 35.58
200-day moving average 33.73

Share statistics

Avg vol (3-month) 387.36k
Avg vol (10-day) 373.17k
Shares outstanding 52.59M
Implied shares outstanding 68.34M
Float 81.57M
% held by insiders 110.42%
% held by institutions 145.05%
Shares short (15 Apr 2024) 412.22k
Short ratio (15 Apr 2024) 40.67
Short % of float (15 Apr 2024) 40.63%
Short % of shares outstanding (15 Apr 2024) 40.47%
Shares short (prior month 15 Mar 2024) 45.13k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Nov 2019
Ex-dividend date 4N/A
Last split factor 21:17
Last split date 326 July 2023

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-35,560.66%

Management effectiveness

Return on assets (ttm)-81.53%
Return on equity (ttm)-178.30%

Income statement

Revenue (ttm)61k
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -21.6M
Net income avi to common (ttm)-21.81M
Diluted EPS (ttm)-236.13
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)20.37M
Total cash per share (mrq)7.86
Total debt (mrq)423k
Total debt/equity (mrq)2.73%
Current ratio (mrq)3.62
Book value per share (mrq)5.97

Cash flow statement

Operating cash flow (ttm)-18.07M
Levered free cash flow (ttm)-9.6M